These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 11096013)
1. Novelties in the field of anti-infective compounds in 1999. Bryskier A Clin Infect Dis; 2000 Dec; 31(6):1423-66. PubMed ID: 11096013 [TBL] [Abstract][Full Text] [Related]
2. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms. Garrison MW; Neumiller JJ; Setter SM Clin Ther; 2005 Jan; 27(1):12-22. PubMed ID: 15763603 [TBL] [Abstract][Full Text] [Related]
3. The antimicrobial armamentarium: evaluating current and future treatment options. Bosso JA Pharmacotherapy; 2005 Oct; 25(10 Pt 2):55S-62S. PubMed ID: 16178676 [TBL] [Abstract][Full Text] [Related]
4. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus. Scheinfeld N J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic options for CNS infections caused by resistant Gram-positive organisms. Peppard WJ; Johnston CJ; Urmanski AM Expert Rev Anti Infect Ther; 2008 Feb; 6(1):83-99. PubMed ID: 18251666 [TBL] [Abstract][Full Text] [Related]
6. Novelties in the field of anti-infectives in 1998. Bryskier A Clin Infect Dis; 1999 Sep; 29(3):632-58. PubMed ID: 10530460 [TBL] [Abstract][Full Text] [Related]
8. Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria. Appelbaum PC; Jacobs MR Curr Opin Microbiol; 2005 Oct; 8(5):510-7. PubMed ID: 16098786 [TBL] [Abstract][Full Text] [Related]
9. [Natural products in clinical trials: antibacterial and antifungal agents]. Han L; Zheng D; Huang XS; Yu SS; Liang XT Yao Xue Xue Bao; 2007 Mar; 42(3):236-44. PubMed ID: 17520820 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives. Liu J; Cao R; Wu Q; Ma C; Wang Z; Peng W; Song H Eur J Med Chem; 2009 Apr; 44(4):1737-44. PubMed ID: 18450331 [TBL] [Abstract][Full Text] [Related]
11. Prospects for the next anti-Pseudomonas drug. Page MG; Heim J Curr Opin Pharmacol; 2009 Oct; 9(5):558-65. PubMed ID: 19748829 [TBL] [Abstract][Full Text] [Related]
12. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Micek ST Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745 [TBL] [Abstract][Full Text] [Related]
13. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients. Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683 [TBL] [Abstract][Full Text] [Related]
14. Telavancin: a new lipoglycopeptide with multiple mechanisms of action. Kanafani ZA Expert Rev Anti Infect Ther; 2006 Oct; 4(5):743-9. PubMed ID: 17140351 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan. Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808 [TBL] [Abstract][Full Text] [Related]
16. DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 1: Internal benzimidazole derivatives. Bürli RW; McMinn D; Kaizerman JA; Hu W; Ge Y; Pack Q; Jiang V; Gross M; Garcia M; Tanaka R; Moser HE Bioorg Med Chem Lett; 2004 Mar; 14(5):1253-7. PubMed ID: 14980676 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909 [TBL] [Abstract][Full Text] [Related]